Anselamimab (CAEL-101) is a chimeric monoclonal antibody for systemic light chain (AL) amyloidosis. Anselamimab can promote phagocytic destruction and subsequent clearance of amyloid deposits. Anselamimab can be used in the research of amyloidosis[1][2].
Molecular Weight:
(144.42 kDa)
Purity:
98.96
CAS Number:
[2414866-63-8]
Target:
Amyloid-beta,Apolipoprotein
Application Notes:
MCE Product type: Inhibitory Antibodies
* VAT and and shipping costs not included. Errors and price changes excepted